Viewing Study NCT05203458


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-01-01 @ 8:10 AM
Study NCT ID: NCT05203458
Status: COMPLETED
Last Update Posted: 2024-05-16
First Post: 2021-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module